Clinical Trial Update: Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines [Phase 4]

View source ↗

Summary

Phase 4 trial update examining immunogenicity when Yellow Fever vaccine is co-administered with MMR vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaccine-induced Immune Response Impairment

Drugs mentioned

• MMR vaccine (Measles, Mumps, and Rubella vaccine)
• Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: Alba Maria Ropero | Conditions: Vaccine Response Impaired | Phase 4 | Status: COMPLETED